ViroAb™ Mouse Anti-HIV GP41 Monoclonal Antibody (XS0012)

Search All

Virus Antibodies

Pseudovirus

Secondary Antibodies

Isotype Controls

Virology Probe

Vaccine Serum

Documents

Datasheet
MSDS
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
Tech Support

Cat#: VRS-0224-YT821

ViroAb™ Mouse Anti-HIV GP41 Monoclonal Antibody (XS0012)

This Mouse Monoclonal antibody is specific for HIV GP41 protein. The antibody can be used for applications: WB, ELISA. The antibody is for Acquired Immune Deficiency Syndrome disease research use only and is not approved for use in humans or in clinical diagnosis.

Made to Order Requirements

Your choose infomation:

CLEAR

(Note: Please select the requirements to fit you project. If you have any other requirements, please specify. If no specific requirements, you don't need to select any button.)

Product Overview
Product Properties
Packaging, Storage & Formulations
Applications

Product Overview

Target :	Env
Target Specific Region :	gp41
Specificity :	HIV gp41
Clone :	XS0012
Host Species :	Mouse
Antibody Isotype :	IgG1
Species Reactivity :	Human Immunodeficiency Virus 1
Virus Subtype :	Human Immunodeficiency Virus 1

Product Properties

Immunogen :	HIV1 gp41 antibody was raised in mouse using recombinant gp41 as the antibody.
Purity :	>95% as determined by SDS-PAGE
Concentration :	Lot specific

Packaging, Storage & Formulations

Form :	Liquid
Formulation :	PBS
Storage :	Store at 4°C for short term. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application :	WB; ELISA
Application Notes :	WB: 1:1000 ELISA: 1:5000 The optimal working dilutions should be determined by the end user.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

pepFastX™ Platform

If no antibody is available for your research, we recommend our novel pepFastX™ antibody discovery platform. The mAb products can be delivered within 2-3 months.

Learn more